210 related articles for article (PubMed ID: 27492369)
1. Relationship Between Antihypertensive Medications and Cognitive Impairment: Part II. Review of Physiology and Animal Studies.
Peters R; Schuchman M; Peters J; Carlson MC; Yasar S
Curr Hypertens Rep; 2016 Aug; 18(8):66. PubMed ID: 27492369
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Antihypertensive Medications and Cognitive Impairment: Part I. Review of Human Studies and Clinical Trials.
Yasar S; Schuchman M; Peters J; Anstey KJ; Carlson MC; Peters R
Curr Hypertens Rep; 2016 Aug; 18(8):67. PubMed ID: 27492370
[TBL] [Abstract][Full Text] [Related]
3. Treating Hypertension to Prevent Cognitive Decline and Dementia: Re-Opening the Debate.
Iulita MF; Girouard H
Adv Exp Med Biol; 2017; 956():447-473. PubMed ID: 27757933
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive medications and risk for incident dementia and Alzheimer's disease: a meta-analysis of individual participant data from prospective cohort studies.
Ding J; Davis-Plourde KL; Sedaghat S; Tully PJ; Wang W; Phillips C; Pase MP; Himali JJ; Gwen Windham B; Griswold M; Gottesman R; Mosley TH; White L; Guðnason V; Debette S; Beiser AS; Seshadri S; Ikram MA; Meirelles O; Tzourio C; Launer LJ
Lancet Neurol; 2020 Jan; 19(1):61-70. PubMed ID: 31706889
[TBL] [Abstract][Full Text] [Related]
5. Treatment options and considerations for hypertensive patients to prevent dementia.
Hernandorena I; Duron E; Vidal JS; Hanon O
Expert Opin Pharmacother; 2017 Jul; 18(10):989-1000. PubMed ID: 28532183
[TBL] [Abstract][Full Text] [Related]
6. Effect of renin-angiotensin system antihypertensive medication use on cognitive function in diabetes mellitus with obesity or overweight: An ancillary study to the Action for Health in Diabetes (Look AHEAD) trial.
Wharton W; Anderson A; Hayden KM; Carmichael OT; Clark JM; Luchsinger JA; Espeland M; Yasar S
Diabetes Obes Metab; 2022 Dec; 24(12):2443-2453. PubMed ID: 36065050
[TBL] [Abstract][Full Text] [Related]
7. Beneficial Effects of Walnuts on Cognition and Brain Health.
Chauhan A; Chauhan V
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32093220
[TBL] [Abstract][Full Text] [Related]
8. Defining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.
Walker KA; Power MC; Gottesman RF
Curr Hypertens Rep; 2017 Mar; 19(3):24. PubMed ID: 28299725
[TBL] [Abstract][Full Text] [Related]
9. Neurovascular and Cognitive Dysfunction in Hypertension.
Iadecola C; Gottesman RF
Circ Res; 2019 Mar; 124(7):1025-1044. PubMed ID: 30920929
[TBL] [Abstract][Full Text] [Related]
10. [The effect of angiotensin receptor blockers in cerebrovascular disorders and dementia: bonus in addition to the antihypertensive effect].
Kovács T
Ideggyogy Sz; 2014 May; 67(5-6):149-68. PubMed ID: 25087375
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Renin-Angiotensin System May Slow Conversion from Mild Cognitive Impairment to Alzheimer's Disease.
Wharton W; Goldstein FC; Zhao L; Steenland K; Levey AI; Hajjar I
J Am Geriatr Soc; 2015 Sep; 63(9):1749-56. PubMed ID: 26389987
[TBL] [Abstract][Full Text] [Related]
12. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.
McGuinness B; Todd S; Passmore P; Bullock R
Cochrane Database Syst Rev; 2006 Apr; (2):CD004034. PubMed ID: 16625595
[TBL] [Abstract][Full Text] [Related]
13. Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden.
Tadic M; Cuspidi C; Hering D
BMC Cardiovasc Disord; 2016 Nov; 16(1):208. PubMed ID: 27809779
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort Study.
Edwards JD; Ramirez J; Callahan BL; Tobe SW; Oh P; Berezuk C; Lanctôt K; Swardfager W; Nestor S; Kiss A; Strother S; Black SE;
J Alzheimers Dis; 2017; 59(3):1113-1122. PubMed ID: 28731439
[TBL] [Abstract][Full Text] [Related]
15. Does use of antihypertensive drugs affect the incidence or progression of dementia? A systematic review.
Shah K; Qureshi SU; Johnson M; Parikh N; Schulz PE; Kunik ME
Am J Geriatr Pharmacother; 2009 Oct; 7(5):250-61. PubMed ID: 19948301
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive drugs, prevention of cognitive decline and dementia: a systematic review of observational studies, randomized controlled trials and meta-analyses, with discussion of potential mechanisms.
Rouch L; Cestac P; Hanon O; Cool C; Helmer C; Bouhanick B; Chamontin B; Dartigues JF; Vellas B; Andrieu S
CNS Drugs; 2015 Feb; 29(2):113-30. PubMed ID: 25700645
[TBL] [Abstract][Full Text] [Related]
17. Effect of Visit-to-Visit Blood Pressure Variability on Cognitive and Functional Decline in Mild to Moderate Alzheimer's Disease.
O'Caoimh R; Gao Y; Svendrovski A; Illario M; Iaccarino G; Yavuz BB; Kehoe PG; Molloy DW
J Alzheimers Dis; 2019; 68(4):1499-1510. PubMed ID: 30909214
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and underlying mechanism of phosphodiesterase- 5 inhibitors in preventing cognitive impairment and Alzheimer pathology: A systematic review of animal studies.
El-Bakly W; Wagdy O; Sobhy A; Abo Elenain O; Riad MS; El Sayed M; Tarkhan S; Yassen M; Mahmoud A; Bassiony M; Nabil N
Behav Brain Res; 2019 Oct; 372():112004. PubMed ID: 31163203
[TBL] [Abstract][Full Text] [Related]
19. NIH state-of-the-science conference statement: Preventing Alzheimer's disease and cognitive decline.
Daviglus ML; Bell CC; Berrettini W; Bowen PE; Connolly ES; Cox NJ; Dunbar-Jacob JM; Granieri EC; Hunt G; McGarry K; Patel D; Potosky AL; Sanders-Bush E; Silberberg D; Trevisan M
NIH Consens State Sci Statements; 2010 Apr; 27(4):1-30. PubMed ID: 20445638
[TBL] [Abstract][Full Text] [Related]
20. Hypertension and cognitive function in the elderly.
Cherubini A; Lowenthal DT; Paran E; Mecocci P; Williams LS; Senin U
Dis Mon; 2010 Mar; 56(3):106-47. PubMed ID: 20189499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
